VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Monday, January 5, 2026
Stock Comparison
Sartorius Stedim Biotech S.A. vs Legrand S.A.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Sartorius Stedim Biotech S.A.
DIM · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Sartorius Stedim Biotech S.A.'s moat claims, evidence, and risks.
View DIM analysisLegrand S.A.
LR · Euronext Paris
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Sartorius Stedim Biotech S.A. leads (80 / 100 vs 68 / 100 for Legrand S.A.).
- Segment focus: Sartorius Stedim Biotech S.A. has 2 segments (75% in Sterile single-use bioprocessing consumables); Legrand S.A. has 2 segments (80% in Building electrical & digital infrastructure (non-datacenter)).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
- Moat breadth: Sartorius Stedim Biotech S.A. has 6 moat types across 3 domains; Legrand S.A. has 4 across 3.
Primary market context
Sartorius Stedim Biotech S.A.
Sterile single-use bioprocessing consumables
Sterile single-use bioprocessing consumables (bags, filters, fluid management components)
Global
Biopharmaceutical manufacturers and CDMOs
Consumables supplier (single-use)
75%
Legrand S.A.
Building electrical & digital infrastructure (non-datacenter)
Low-voltage electrical and digital building infrastructure (wiring devices, energy distribution, cable management, building controls)
Global (strong Europe & North America footprint)
Professional installers/electricians, electrical wholesalers, OEM/contractors; end-users in residential & commercial buildings
Manufacturer + brand owner; channel-driven distribution
80%
Side-by-side metrics
Moat coverage
Shared moat types
Sartorius Stedim Biotech S.A. strengths
Legrand S.A. strengths
Segment mix
Sartorius Stedim Biotech S.A. segments
Full profile >Sterile single-use bioprocessing consumables
Oligopoly
Bioprocessing equipment, systems, and software/services
Oligopoly
Legrand S.A. segments
Full profile >Building electrical & digital infrastructure (non-datacenter)
Oligopoly
Datacenter infrastructure
Oligopoly
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.